Physician profile
Robert E Mcmichael
NPI 1205985934
$1,545.54
in general payments reported to CMS, 2019-2025
27 companies · $13.48 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2021: $294 · 2022: $281 · 2023: $583 · 2024: $243 · 2025: $13.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.85 |
| Education | $151.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $447.33 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $159.47 | 2022-2023 | Austedo Xr |
| 3b Medical, INC. | $99.17 | 2023 | Luna |
| Pfizer INC. | $89.61 | 2023-2024 | |
| Harmony Biosciences LLC | $64.99 | 2024 | |
| Lilly USA, LLC | $61.46 | 2019-2023 | Reyvow, Emgality |
| Idorsia Pharmaceuticals US INC | $57.80 | 2023 | Quviviq |
| Kyowa Kirin, INC. | $47.01 | 2021 | |
| Tanabe Pharma America, INC. | $46.24 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $44.06 | 2021-2024 | |
| Abbott Laboratories | $43.96 | 2023 | Infinity |
| Novartis Pharmaceuticals Corporation | $42.28 | 2019 | |
| Scilex Pharmaceuticals INC. | $36.83 | 2023 | Ztlido |
| Biogen, INC. | $34.18 | 2022-2023 | Spinraza |
| Genzyme Corporation | $31.09 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $27.71 | 2024 | |
| Emd Serono, INC. | $23.44 | 2019 | |
| Horizon Therapeutics Plc | $22.72 | 2023 | Uplizna |
| Fisher & Paykel Healthcare INC | $21.09 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.87 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.59 | 2021 | |
| Inspire Medical Systems, INC. | $20.16 | 2023 | Inspire |
| Amgen INC. | $19.70 | 2022 | |
| Medtronic USA, INC. | $17.21 | 2019 | |
| Sarepta Therapeutics, INC. | $16.67 | 2021 | |
| Philips North America LLC | $16.42 | 2023 | |
| Acadia Pharmaceuticals INC | $13.48 | 2025 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.